Institut für Chemie und Biochemie, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany.
Sphingotec Therapeutics GmbH, Neuendorfstr. 15a, 16761, Hennigsdorf, Germany.
Sci Rep. 2018 Jan 30;8(1):1916. doi: 10.1038/s41598-018-19530-8.
Regulated intramembrane proteolysis of the amyloid precursor protein (APP) and its homologs, the APP like proteins APLP1 and APLP2, is typically a two-step process, which is initiated by ectodomain-shedding of the substrates by α- or β-secretases. Growing evidence, however, indicates that the cleavage process for APLP1 is different than for APP. Here, we describe that full-length APLP1, but not APP or APLP2, is uniquely cleaved by γ-secretase without previous ectodomain shedding. The new fragment, termed sAPLP1γ, was exclusively associated with APLP1, not APP, APLP2. We provide an exact molecular analysis showing that sAPLP1γ was uniquely generated by γ-secretase from full-length APLP1. Mass spectrometry analysis showed that the sAPLP1γ fragment and the longest Aβ-like peptide share the C-terminus. This novel mechanism of γ-secretase action is consistent with an ϵ-cut based upon the nature of the reaction in APP. We further demonstrate that the APLP1 transmembrane sequence is the critical determinant for γ-shedding and release of full-length APLP1. Moreover, the APLP1 TMS is sufficient to convert larger type-I membrane proteins like APP into direct γ-secretase substrates. Taken together, the direct cleavage of APLP1 is a novel feature of the γ-secretase prompting a re-thinking of γ-secretase activity modulation as a therapeutic strategy for Alzheimer disease.
淀粉样前体蛋白(APP)及其同源物,如 APP 样蛋白 APLP1 和 APLP2 的调节性膜内蛋白水解通常是一个两步过程,该过程由 α-或 β-分泌酶启动底物的外结构域脱落。然而,越来越多的证据表明,APLP1 的切割过程与 APP 不同。在这里,我们描述全长 APLP1 可被 γ-分泌酶切割,而无需先前的外结构域脱落,这是 APLP1 所特有的。新的片段,称为 sAPLP1γ,仅与 APLP1 而不是 APP 或 APLP2 相关。我们提供了一个精确的分子分析,表明 sAPLP1γ 是由全长 APLP1 独特地由 γ-分泌酶生成的。质谱分析表明,sAPLP1γ 片段和最长的 Aβ 样肽共享 C 末端。这种 γ-分泌酶作用的新机制与 APP 中反应的本质一致,基于 ε-切割。我们进一步证明 APLP1 跨膜序列是 γ-脱落和全长 APLP1 释放的关键决定因素。此外,APLP1 TMS 足以将 APP 等较大的 I 型膜蛋白直接转化为 γ-分泌酶底物。总之,APLP1 的直接切割是 γ-分泌酶的一个新特征,这促使人们重新思考 γ-分泌酶活性调节作为阿尔茨海默病的治疗策略。